Search

everythinglearnresearchcommunity

for

Search:↓

Metabolic syndrome and PCOS are related but separate conditions, with metabolic syndrome increasing the risk of heart disease and diabetes.

Metformin combined with lifestyle changes improves insulin resistance and reduces testosterone levels in women with PCOS more than lifestyle changes alone.

The research found how GPCR Class A Rhodopsin receptors are related and suggested possible substances they interact with.

Women with PCOS are more likely to have sleep apnea, mainly if they are obese.

Some skin conditions may indicate metabolic syndrome, which could help with early detection and management of related health issues.

High androgen levels in Chinese women with PCOS are linked to a higher risk of diabetes and obesity.

Inhibitors of 11β-HSD1 show potential for treating type 2 diabetes but require more testing for safety and effectiveness.

Women with PCOS are more likely to have insulin resistance and obesity, especially those with the most severe type I PCOS.

More PDCD4 is linked to obesity, insulin problems, and cell death in ovaries for those with polycystic ovary syndrome.

Insulin-sensitizing drugs like metformin can help with ovulation, weight loss, and lower testosterone in some women with PCOS.

Low testosterone and 5α-reductase inhibitors can harm men's metabolic and sexual health; testosterone therapy may help, but discussing 5α-RIs' side effects is important.

Young women with PCOS have a higher risk of high blood pressure and metabolic syndrome, but these risks may decrease after age 40.

Small changes in hormones can significantly impact health, showing the importance of sensitive testing for chemicals that disrupt hormones.

Men taking dutasteride or finasteride have a slightly higher risk of developing type 2 diabetes.

Exercise improves insulin sensitivity and hormone regulation in PCOS rats.

Greek women with PCOS have a higher risk of metabolic syndrome and are more likely to be overweight compared to healthy controls.

Lower lipin 1β in belly fat is linked to insulin resistance in people with polycystic ovary syndrome.

Women with PCOS have higher levels of a certain growth factor, which can be reduced by taking metformin.

Eating less starch and dairy helped overweight women with PCOS lose weight and improve symptoms.

Skin problems in older people can indicate hormonal diseases, nutritional deficiencies, or conditions like diabetes, menopause, and HIV.

Normal levels for certain hormones in Chinese women of reproductive age were identified.

Many infertile women with PCOS in Central Vietnam have metabolic or insulin resistance syndrome, with obesity and older age increasing the risk.

Changing the diagnosis criteria for PCOS might miss women at risk for related health issues.

Overweight women with PCOS have higher levels of certain hormones that could indicate a higher risk of heart and metabolic problems.

Obese Hispanic women with PCOS are at higher risk for metabolic problems than non-Hispanic white women.

Type 2 diabetes does not change how metformin works in obese pregnant women, so dosage adjustments are not needed.

Lower vaspin levels in the blood may indicate a better response to fertility treatment in women with PCOS.

Exercise and finasteride together improve ovary health in PCOS rats.

The conclusion is that a new test was created to find substances that affect specific ion channels, and it works well for drug discovery.

Women with PCOS have more insulin resistance and are more likely to have heart-related health issues, with insulin resistance being a bigger factor than β-cell problems.